Inventor

Calvin B. Harley

Inventor

Palo Alto, CA, US

Overview

1997–2019

Patent span

Chemistry

Primary field (CPC C)

Patents· 47 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes19%

C12NMicroorganisms or enzymes18%

C12YEnzymes14%

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms12%

A01KAnimal husbandry10%

C07KPeptides10%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations8%

Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests3%

C07JSteroids2%

G01NInvestigating or analysing materials by determining their chemical or physical properties2%

PatentTitleYear

10,316,366Measures of short telomere abundance2019 10,196,677Method for identification of sensitivity of a patient to telomerase inhibition therapy2019 9,944,978Multiplex quantitative PCR2018 9,913,851'Compositions and methods for increasing telomerase activity'2018 9,617,583'Method for identification of sensitivity of a patient to telomerase inhibition therapy'2017 9,403,866'Compositions and methods for increasing telomerase activity'2016 9,248,088'Compositions and methods for skin conditioning'2016 8,877,723'Method for identification of sensitivity of a patient to telomerase inhibition therapy'2014 8,759,304'Compositions and methods for increasing telomerase activity'2014 8,709,995'Method for eliciting an immune response to human telomerase reverse transcriptase'2014 8,481,721'Compositions and methods for increasing telomerase activity'2013 8,236,774'Human telomerase catalytic subunit'2012 8,222,392'Kit for detection of telomerase reverse transcriptase nucleic acids'2012 7,846,904'Compositions and methods for increasing telomerase activity'2010 7,750,121'Antibody to telomerase reverse transcriptive'2010 7,622,549'Human telomerase reverse transcriptase polypeptides'2009 7,585,622'Increasing the proliferative capacity of cells using telomerase reverse transcriptase'2009 7,560,437'Nucleic acid compositions for eliciting an immune response against telomerase reverse transcriptase'2009 7,517,971'Muteins of human telomerase reverse transcriptase lacking telomerase catalytic activity'2009 7,413,864'Treating cancer using a telomerase vaccine'2008 7,297,488'Identifying and testing antisense oligonucleotides that inhibit telomerase reverse transcriptase'2007 7,285,639'Antibody to telomerase reverse transcriptase'2007 7,262,174'Treatment for wounds'2007 7,262,288'Nucleic acids encoding human telomerase reverse transcriptase and related homologs'2007 7,195,911'Mammalian cells that have increased proliferative capacity'2007 7,056,513'Telomerase'2006 7,005,262'Methods for detecting nucleic acids encoding human telomerase reverse transcriptase'2006 6,927,285'Genes for human telomerase reverse transcriptase and telomerase variants'2005 6,921,664'Telomerase'2005 6,808,880'Method for detecting polynucleotides encoding telomerase'2004 6,627,619'Antisense compositions for detecting and inhibiting telomerase reverse transcriptase'2003 6,617,110'Cells immortalized with telomerase reverse transcriptase for use in drug screening'2003 6,551,774'Diagnostic methods for conditions associated with elevated cellular levels of telomerase activity'2003 6,475,789'Human telomerase catalytic subunit: diagnostic and therapeutic methods'2002 6,444,650'Antisense compositions for detecting and inhibiting telomerase reverse transcriptase'2002 6,391,554'Detecting cancerous conditions by assaying for telomerase activity'2002 6,261,836'Telomerase'2001 6,007,989'Methods of screening for compounds that derepress or increase telomerase activity'1999 5,989,807'Detecting cancerous conditions by assaying for telomerase activity'1999 5,972,605'Assays for regulators of mammalian telomerase expression'1999 5,891,639'Telomerase activity assays'1999 5,863,726'Telomerase activity assays'1999 5,840,490'Telomerase activity associated with hematological and colorectal malignancies'1998 5,837,453'Telomerase activity assays'1998 5,804,380'Telomerase activity assays'1998 5,645,986'Therapy and diagnosis of conditions related to telomere length and/or telomerase activity'1997 5,629,154'Telomerase activity assays'1997

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1997–2019Patents assigned to GERON CORP (31)· patent assignee history

1997–2010Based in Palo Alto, CA, US· patent location history

2001–2005Patents assigned to UNIV TECHNOLOGY CORP (6)· patent assignee history

2004–2014Patents assigned to UNIV COLORADO (15)· patent assignee history

2010–2019Based in Murphys, CA, US· patent location history

2012–2016Patents assigned to HARLEY CALVIN B (6)· patent assignee history

2013–2018Patents assigned to TELOMERASE ACTIVATION SCIENCES INC (4)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
GERON CORP	31	1997–2019
UNIV COLORADO	15	2004–2014
HARLEY CALVIN Bself	6	2012–2016
UNIV TECHNOLOGY CORP	6	2001–2005
TELOMERASE ACTIVATION SCIENCES INC	4	2013–2018

Locations

Location	Patents	Span
Palo Alto, California, US	33	1997–2010
Murphys, California, US	14	2010–2019